The FDA added Pfizer's antidepressant drug Zoloft and generic sertraline to the list of drugs in short supply amid a spike in demand as the pandemic takes a toll on mental health. Generic-drug companies that make sertraline said they have had difficulty securing enough of the active pharmaceutical ingredient used to make the drug, while Pfizer makes its own API but said some bottles and formulations are in short supply.
FDA adds antidepressant Zoloft to shortage list
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.